Coya Therapeutics is a company that provides cell therapy platform developing treatments focused on the biology and potential therapeutic advantages of regulatory T cells (Tregs) to target systemic inflammation and neuroinflammation. Its product candidate pipeline leverages multiple therapeutic modalities aimed at restoring the anti-inflammatory and immunomodulatory functions of Tregs. The company is focused on the advancement of therapeutic approaches to address the medical needs of patients with neurodegenerative, autoimmune, and metabolic diseases.